-
Netarsudil and latanoprost combo useful fixed dose option for open-angle glaucoma and IOP: Study
16 Apr 2024 21:54 GMT
… insufficiently controlled by topical medication. The efficacy and safety … between the two treatments. Both treatments demonstrated a mean … of the findings by stating that once-daily NET… comparison of netarsudil/latanoprost and bimatoprost/timolol …
-
Case report: Cryopreserved amniotic membrane used for glaucoma medication-induced dry eye
05 Apr 2024 16:46 GMT
… of timolol, brimonidine tartrate and latanoprost to manage her glaucoma. Previously … ocular hypotensive drops; however, these medications are typically associated with ocular … beneficial for patients with glaucoma treatment-induced DED, and early initiation …
-
Qlaris Bio Advances QLS‑111 into Phase 2 Trials for Ocular Hypertension and Glaucoma Treatment
04 Apr 2024 14:45 GMT
… masked, randomized clinical trials are designed to investigate … critical need for new treatments, stating, “IOP remains the … in combination with latanoprost versus latanoprost alone. This study … with current glaucoma medications, noting its strong safety …
-
Qlaris Bio initiates trials for potassium channel modulator therapy in glaucoma patients
03 Apr 2024 20:04 GMT
… The Osprey and Apteryx trials will assess QLS-111, … press release No current medications directly address distal outflow … in combination with existing treatments, QLS-111 has the … latanoprost compared with latanoprost alone, according to the release. The trial …
-
Qlaris Bio’s Novel IOP-Lowering Product, QLS‑111, is Dosed in Phase II Trials
02 Apr 2024 15:25 GMT
… Qlaris”), a clinical-stage biotechnology company targeting unmet needs in … for the treatment of glaucoma, and additional treatments are … currently on latanoprost will be enrolled in the trial.
“We … drug classes, indicating that its use with current medications …
-
Improved Glaucoma Medication Access Through Pharmacy Partnership: A Single Institution Experience
02 Apr 2024 10:05 GMT
… medications such as generic dorzolamide-timolol, brimonidine, and latanoprost … name versus generic drugs for the treatment of glaucoma. … the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 … , et al. Treatment patterns and medication adherence of patients …
-
Qlaris Bio’s Novel IOP-Lowering Product, QLS‑111, is Dosed in Phase II Trials
02 Apr 2024 16:18 GMT
… Qlaris”), a clinical-stage biotechnology company targeting unmet needs in … for the treatment of glaucoma, and additional treatments are … currently on latanoprost will be enrolled in the trial.
“We … drug classes, indicating that its use with current medications …
-
Dry Eye Disease Market Report 2032: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
23 Mar 2024 00:00 GMT
… trial GOBI, which is one of two pivotal Phase 3 trials … (netarsudil and latanoprost ophthalmic solution) … drugs.
Key Dry Eye Disease Companies: Alcon, Allysta Pharmaceuticals, Aramis Biosciences, BRIM Biotechnology … Current Treatment and Medical Practices
…
-
Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of Ophthalmology
20 Mar 2024 06:30 GMT
… pivotal Phase 3 trial comparing NCX 470 to latanoprost in the … of Ophthalmology at SUNY Upstate Medical University, Syracuse, NY and … Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle … of the U.S. New Drug Application (NDA) is expected …
-
Human medicines European public assessment report (EPAR): Catiolanze, latanoprost, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised
13 Feb 2024 18:36 GMT
When pressure in the eye increases, it can cause damage to the retina (the light-sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain. This can result in serious vision loss and even blindness.
The …